Navigation Links
ALS Patients and Researchers Unite in Boston for 4th Annual Leadership Summit
Date:9/24/2008

Panel of ALS Researchers to Present and Consider the Latest Therapeutic Approaches

CAMBRIDGE, Mass., Sept. 24 /PRNewswire-USNewswire/ -- The ALS Therapy Development Institute (ALS TDI) announced the line-up for its upcoming, annual ALS research symposium, part of the fourth annual ALS TDI Leadership Summit. The symposium will take place this October 20th at the Beacon Hill Holiday Inn in Boston, Mass. A diverse panel of scientists will provide presentations on the development of effective treatments, or a cure, for amyotrophic lateral sclerosis (ALS, commonly known as Lou Gehrig's disease). After each presentation, audience members are invited to offer comments and ask questions regarding the research. Several of the guest speakers will participate in a panel discussion to take place between the morning and afternoon sessions. The entire event is being offered free of charge by ALS TDI.

"There is a need in the ALS community for openness and directness when it comes to describing what is done with all the monies donated for research. Providing unbiased access to information and researchers is one of the pillars of the ALS TDI philosophy. This annual event provides a unique setting for patients and researchers to connect in pursuit of a shared goal," said John McCarty, Ph.D., Director of Therapeutic Investigation at ALS TDI.

The following is a list of confirmed researchers and proposed presentation topics:

-- "Our Plan, Our Progress, Your Lab," Sean Scott, President, ALS

TDI, Cambridge, Mass.;

-- "The MDA Commitment," Sharon Hesterlee, Ph.D., Vice President

for Translational Research, Muscular Dystrophy Association, Tucson,

Ariz.;

-- "Towards defining the molecular basis of ALS: clues from

TDP-43," Michael J. Strong, M.D., Co-Chair, Department of Clinical

Neurological Sciences, Arthur J. Hudson Chair in ALS Research, London

Health Sciences Centre, Londo
'/>"/>

SOURCE ALS Therapy Development Institute
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine news :

1. Ovarian and Endometrial Cancer Patients Experience Improved Outcomes When Treated First by a Gynecologic Oncologist
2. Hormone Therapy Not Best for Older Prostate Cancer Patients
3. Whole brain radiation increases risk of learning and memory problems in cancer patients
4. Results From IMPROVE Study Show Therapeutic Effect of New Formulation of Rebif(R) at 16 Weeks in Patients With Multiple Sclerosis
5. Book Proceeds Help Cancer Patients at Phoenix Childrens Hospital
6. Strategies for preventing gastrointestinal complications in severely burned patients
7. The prevalence of hepatitis B virus infection in inflammatory bowel disease patients
8. How to treat gastroesophageal adenocarcinom patients?
9. SpectraScience Delivers Cancer Diagnosis System to Mayo Clinic and UCSD/VA for Detecting Esophageal Dysplasia in Patients
10. Web Site Helps Cancer Patients With Fertility Preservation
11. Girling Health Care Employees and Patients Urged to Call for Instructions
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/19/2013)... 19, 2013 Brightree LLC , ... software solutions for the post-acute care industry, has been ranked ... the Healthcare Informatics 100 (HCI 100) list. This ... the U.S. in terms of revenue during the last fiscal ... rate of 85% annually, and the company has built its ...
(Date:6/19/2013)... Boca Raton, FL (PRWEB) June 19, 2013 ... spoke about the positive changes and growth that has occurred ... his nationwide travel club. , Shuman said, "Travel Services has ... program to heights beyond belief. Membership is up, even ... agents to meet the demands of members." , Having been ...
(Date:6/19/2013)... disease Amyotrophic lateral sclerosis (ALS), also known as Lou ... can be classified into four distinct stages, report pathologists ... of Pennsylvania in the Annals of Neurology . ... tissues shows, for the first time, how the fatal ... the central nervous system to other regions of brain ...
(Date:6/19/2013)... derived from a naturally occurring compound (apocynin), has ... with Parkinson,s Disease symptoms by preventing deficits in ... the May 28, 2013 edition of ... postdoctoral fellow at the Medical College of Wisconsin ... Balaraman Kalyanaraman, Ph.D., Harry R. & Angeline ...
(Date:6/19/2013)... Imprivata ®, a leading global provider ... Imprivata OneSign ® leads the single sign-on (SSO) category ... & Services report . CIOs and other healthcare executives ... performance of its products and the quality of its ... is integral to their long-term healthcare IT strategy. ...
Breaking Medicine News(10 mins):Health News:Brightree Debuts on List of Top 100 Healthcare Technology Companies 2Health News:Brightree Debuts on List of Top 100 Healthcare Technology Companies 3Health News:Former Owner Eric Shuman Endorses New Owners and Changes Made in Last Year Since Shuman Sold Travel Services Center at Member Conference 2Health News:Staging system in ALS shows potential tracks of disease progression, Penn study finds 2Health News:Imprivata Tops Single Sign-On Category in KLAS 2013 Mid-Term Performance Review 2Health News:Imprivata Tops Single Sign-On Category in KLAS 2013 Mid-Term Performance Review 3
... one of the worlds leading causes of blindness could be ... discovery here. , In experiments with laboratory rats, scientists at ... a potential new therapy for uveitis the inflammation of ... the outer surface of the eyeball and includes the iris. ...
... ... Sept. 28 Registered nurses at up to 16,Northern California hospitals, ... strike in October that could involve up to 5,500 RNs at,facilities ... Yuba City and Marysville. Strike notices are being sent today ...
... VAWith extensively drug-resistant tuberculosis, life-threatening drug-resistant respiratory and ... headlines, infectious diseases physicians are applauding Rep. Jim ... introducing H.R. 3697, the Strategies To Address Antimicrobial ... The STAAR Act has the potential to save ...
... 28 Healthcare,Technologies Ltd. (NASDAQ: HCTL ), ... meeting of its shareholders for the approval of,the ... Bioventures,Inc. and Gamida for Life B.V., originally scheduled ... to allow shareholders additional time to fully consider,the ...
... Curtail Infant,Deaths, WASHINGTON, Sept. 28 The ... new civil rights issue" and,requires a revised set ... by the Joint Center for Political and Economic,Studies., ... to Love: Infant Mortality,Commission, which was established by ...
... program is improving air quality, agency claims , , FRIDAY, ... (NOx) from power plants, cars and other industry are ... for less ozone and therefore less smog and healthier ... NOx Budget Trading Program annual report from the U.S. ...
Cached Medicine News:Health News:New discovery may improve treatment of one of the world's leading causes of blindness 2Health News:RNs to Announce October Strike of 5,500 Nurses 2Health News:Infectious diseases experts applaud bill against 'bad bugs' 2Health News:Healthcare Technologies to Reschedule the Shareholders Meeting to Approve the NexGen Biofuels Transaction 2Health News:Healthcare Technologies to Reschedule the Shareholders Meeting to Approve the NexGen Biofuels Transaction 3Health News:Joint Center Says New Approach Required to Reduce Black Infant Mortality 2Health News:Joint Center Says New Approach Required to Reduce Black Infant Mortality 3Health News:Less Smog Now in Eastern U.S.: EPA 2
(Date:6/19/2013)... , June 19, 2013   Life Technologies ... a licensing agreement granting Suzhou Ribo Life Sciences ... siRNA therapeutics in China ... formulate proprietary siRNA molecules in combination with Invivofectamine® ... address human diseases with high unmet medical need ...
(Date:6/19/2013)... , 19. Juni 2013 ... mit der Entwicklung von SCS microRESIST™, ... in der Beschichtung mit Parylene gelungen ... von biokompatiblem Parylene mit antimikrobiellen Eigenschaften ... schädlicher Mikroorganismen auf beschichteten medizinischen Geräten. ...
(Date:6/18/2013)... , June 18, 2013  Intercept Pharmaceuticals, Inc.  ... company focused on the development and commercialization of novel ... announced the pricing of an underwritten public offering of ... offering price of $33.01 per share.  In addition, Intercept ... up to an additional 259,500 shares of common stock. ...
Breaking Medicine Technology:Life Technologies Signs Licensing Agreement with Suzhou Ribo Life Sciences for Development of siRNA Therapeutics in China 2Life Technologies Signs Licensing Agreement with Suzhou Ribo Life Sciences for Development of siRNA Therapeutics in China 3Life Technologies Signs Licensing Agreement with Suzhou Ribo Life Sciences for Development of siRNA Therapeutics in China 4Specialty Coating Systems gibt die Einführung einer neuen antimikrobiellen Parylene-Technologie bekannt 2Intercept Pharmaceuticals Announces Pricing of Public Offering of Common Stock 2
Liquichek Autoimmune Controls are individual controls for monitoring the performance of autoimmune assays....
... BD Beaver Clear Cornea Incision System ... specifically for the Cataract surgeon. The System ... an alternative to costly diamond knives. ... shield that is designed to both protects ...
... Carl Zeiss Meditec's technological expertise ... retinal disease became apparent with revolutionary ... system. Now, with the introduction of ... expertise is being applied to high-resolution, ...
... the eyeglasses in the EZ Meter and ... automatically display the measurement results on its ... detection to data printout makes this the ... and private offices.,In addition to being extremely ...
Medicine Products: